News
UK biotech company Cambridge Antibody Technology says it remains on target to reach profitability by 2008 despite a doubling of its operating losses...
Xenova has halted phase III clinical trials of its lead product after an independent safety committee confirmed safety fears about the drug.
The crisis surrounding the proposed new GP contract has deepened after doctors refused to be tampededinto accepting a new contract, which many say...
Fred Hassan has announced a major re-organisation of Schering-Plough pharmaceutical operations just 17 days after taking on the job of turning around...
AstraZeneca has received a boost with the release of two positive studies for its new blood-thinning drug Exanta despite questions remaining over its...
One of the UK leading cancer hospitals will be forced to restrict access to treatment because of a shortage of funds.
The agreement between the UK government and the pharmaceutical industry which controls company profits is to be reviewed.
Roche and health call-centre specialists International SOS have launched the UK first ever helpline to proactively support patients to keep taking...
GlaxoSmithKline has gained FDA approval for an extended release version of its antidepressant Wellbutrin, giving the company vital new patent...
Private sector companies have been invited to run the latest wave of new diagnostic treatment centres (DTC) to help cut waiting times for routine...